Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision label Revision: v3.6.4 appears on the page, replacing the previous v3.6.3. This indicates a minor update to the page's version without altering the study details.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a newly released iteration of the page's content. This update appears to be a technical revision rather than a change in user-facing information.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This reflects a minor update or maintenance release of the page rather than a change to study details or content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now signals that recruitment is closed to new participants and adds How to Read a Study Record, Common Questions, and How to Join a Study for user guidance. The Interventions header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision indicator was updated to Revision: v3.6.0.SummaryDifference0.2%

- Check61 days agoChange DetectedA new revision tag 'Revision: v3.5.5' has been added, and the previous 'Revision: v3.5.4' has been removed. This signals a refreshed release of the page content.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a software/build update for the page. This change does not alter the study content or public-facing information.SummaryDifference0.0%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.